EXTROVIS
Attila Komaromy is currently the Business Development Director Europe at EXTROVIS. Prior to this, Attila held positions such as Head of Sales and Marketing at KFKI Research Institute For Particle and Nuclear Physics, Business Line Leader at KFKI - Institute of Isotopes, International Business Developer at Telemedia, COD Manager at Teva Pharmaceuticals, and Export Customer Services Manager Europe & Russia at Novartis. Attila holds an MBA from Brunel University, Uxbridge, UK and a degree in Economics from Foreign Trade College in Budapest, Hungary.
This person is not in any offices
EXTROVIS
Extrovis is a fully integrated global pharmaceutical company with strong portfolio offering, comprising of Active Pharmaceutical Ingredients (APIs), Finished dosage forms (FDF) & Custom Pharmaceutical Services. Based in Switzerland, with global presence in North America, India and South America, we are supported by strong network to deliver products across geographies. Our state-of-the-art manufacturing facilities and R&D centers comply with highest international quality standards with accreditions from the USFDA, PMDA, EU and other global regulatory bodies. Our contributions in the area of education and health to financially under privileged reinforces our social commitment. Our mission is to become a reliable partner by offering high quality APIs, FDFs, custom pharmaceutical services and delivering value to our customers, stake holders and patients. Backed by our EXTROrdinary VISion, we have our eyes set on becoming a leading pharmaceutical company in the world.